Will Clorox’s (CLX) Push Into Tech Hygiene Reshape Its Competitive Edge?

• CloroxPro recently launched Screen+ Sanitizing Wipes, a new product designed to safely clean and sanitize electronic devices such as touchscreens, laptops, tablets, and keyboards, addressing the spread of bacteria on shared devices.
• This innovation targets a growing demand for high-quality solutions that maintain tech hygiene in workplaces, schools, and tech-centric settings, where a majority of people prioritize cleaning screens.
• We'll explore how Clorox's entry into the electronic cleaning market with this specialized product shapes its broader investment outlook.

These 10 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.

Clorox Investment Narrative Recap

To be a Clorox shareholder today, you need to trust in the company’s power to innovate in hygiene and cleaning, even as near-term sales face uncertainty. The launch of Screen+ Sanitizing Wipes opens a specialized electronics segment and demonstrates a push for differentiated solutions, but this doesn’t materially change the key catalyst, Clorox’s need to regain top-line growth, or the biggest risk, which is ongoing sluggish demand across core categories and heightened competition.

The recent dividend increase, raising the quarterly payout to US$1.24 per share, stands out alongside this new product launch. While the dividend offers consistency and could appeal amid slow category growth and competitive pressure, the earnings outlook and revenue forecast remain under pressure, reinforcing that operational improvement and category recovery are still central catalysts shaping investor sentiment.

On the flip side, investors should also be aware of the uncertainty around consumer demand, which means...

Read the full narrative on Clorox (it's free!)

Clorox's outlook anticipates $7.0 billion in revenue and $881.8 million in earnings by 2028. This reflects a -0.4% annual revenue decline and a $71.8 million increase in earnings from the current $810.0 million.

Uncover how Clorox's forecasts yield a $133.59 fair value, a 8% upside to its current price.

Exploring Other Perspectives

Five members of the Simply Wall St Community place Clorox's fair value between US$98.22 and US$213.67, signaling a wide span of independent views. As category growth slows and competition intensifies, it is clear there are sharply different opinions about the company’s recovery prospects and long-term returns.

Explore 5 other fair value estimates on Clorox - why the stock might be worth 20% less than the current price!

Build Your Own Clorox Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your Clorox research is our analysis highlighting 5 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Clorox research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Clorox's overall financial health at a glance.

Searching For A Fresh Perspective?

Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:

• The end of cancer? These 29 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.
• Trump's oil boom is here - pipelines are primed to profit. Discover the 22 US stocks riding the wave.
• Explore 24 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com